Stocks Most Loved and Shunned by Hedge and Mutual Funds
Snowflake, JD.com And Temu Parent PDD Are Among Top 8 Large Cap Losers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today
5 Things You Need to Know About COVID, Flu and RSV Vaccines This Fall
The FDA Approved a New Covid Vaccine. Should You Get It? -- Update 2 -- WSJ
U.S. to Restart Free COVID Test Program as Cases Spike
Express News | U.S. CDC Says For This Season Peak Hospitalizations For For Flu And Covid Combined Is Forecasted To Be Similar Or Slightly Improved Over Last Season; Covid Continues To Cause More Serious Disease Than Flu
Express News | US Cdc Official Says Covid Continues to Cause More Serious Disease Than Flu -Press Conference
Express News | US Cdc Says for This Season Peak Hospitalizations for for Flu and Covid Combined Is Forecasted to Be Similar or Slightly Improved Over Last Season-Press Conference
Express News | US Hhs Says Has Launched New National Campaign to Educate Audiences at High Risks of Flu, Covid, 19 and Rsv -Press Conference
Express News | US Cdc Says Free at Home, Covid 19 Test Delivery Programs Will Reopen in Late September -Press Conference
Stocks On Sale: TD, NetEase, Moderna, and Intel
Moderna Wins European Commission Approval for Respiratory Syncytial Virus Vaccine
Sector Update: Health Care Stocks Rise Premarket Friday
Piper Sandler Maintains Moderna(MRNA.US) With Buy Rating, Maintains Target Price $157
Express News | Moderna: Moderna Receives European Commission Approval for Rsv Vaccine Mresvia(R)
Moderna's RSV Vaccine Receives EU Approval for Older Adults
Update: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, BioNTech
Express News | Moderna Gains Approval In Japan For Partial Change Application For Updated COVID-19 MRNA Vaccine Targeting SARS-COV-2 Variant JN.1